Document is current
Any future updates will be listed below
-
Authors
Georgevici, Adrian-Iustin http://orcid.org/0000-0002-2710-2280
Kyprianou, Theodoros
Herzog-Niescery, Jennifer
Procopiuc, Livia
Loganathan, Sivakkanan
Weber, Thomas Peter
Bellgardt, Martin
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03860129 at ClinicalTrials.govDocuments that mention this clinical trial
Use of MIRUS™ for MAC-driven application of isoflurane, sevoflurane, and desflurane in postoperative ICU patients: a randomized controlled trial
https://doi.org/10.1186/s13613-019-0594-8
Negative drift of sedation depth in critically ill patients receiving constant minimum alveolar concentration of isoflurane, sevoflurane, or desflurane: a randomized controlled trial
https://doi.org/10.1186/s13054-021-03556-y
-
Funding
Funding for this research was provided by:
Ruhr-Universität Bochum
- License Information
-
More Information
Article History
Received: 30 December 2020
Accepted: 30 March 2021
First Online: 13 April 2021
Declarations
:
: The Institutional Review Board of the Ruhr University Bochum (No. 4780-13, Chair Prof. M. Zenz) approved the study, registered at ClinicalTrials.gov (NCT03860129, on 24 September 2018). This study was conducted in complete compliance with the Declaration of Helsinki (2013), and all patients provided written informed consent before study participation.
: All authors consented to the publication.
: Bellgardt und Herzog-Niescery received speaker's honoraria from Pall Medical, Dreieich, Germany. The other authors declare that they have no conflict of interest.
